MediLexicon Logo
MediLexicon Logo
Abbreviations        Abbrev Definitions        Dictionary        ICD9 Codes        Equipment        Hospitals        Drugs        More..
  

Useful Websites

Medical Tourism
Compare and save on surgery

Global Translations
Medical and Clinical Translation

specialistinfo.com
Details of over 40,000 UK Specialists and over 42,000 GPs

Global RPH
medical software

Doctors Lounge
Ask a Doctor and Disease Information

Health News
from Medical News Today.

MRCP 1 Revision
123 Doc medical courses for junior doctors.

CoreyNahman
pharmaceutical news daily

Hospital Search
Worldwide hospital database, search by country or keyword.

Metric Conversions
The Converter Site - unit conversion tool.
headlines news headlines   email email to a friend   printer printer friendly   newsletter sign up to newsletter  

Breast Cancer Campaign: New Breast Cancer Research Funding For Belfast

Main Category: Breast Cancer
Also Included In: Cancer / Oncology
Article Date: 19 Nov 2009

Individualised radiotherapy treatment based on a person's genetic make up could soon become a reality, according to Breast Cancer Campaign.

Professor Kevin Prise from Queen's University Belfast has been awarded a three year project grant by the charity to study how genes are involved in the effectiveness of radiotherapy treatment for breast cancer.

The grant, worth more than £160,000, is part of £2 million awarded to 20 projects in the UK and Ireland.

Radiotherapy is given to women with breast cancer to destroy any remaining breast cancer cells after surgery and limit the chance of the disease returning. However, it is believed that a range of genes including BRCA1, BRCA2 and Fanconi Anemia work together to prevent the cells being destroyed by radiotherapy, as they appear to repair the damage caused to the DNA of breast cancer cells.

In the laboratory at Queen's, Professor Prise and his team will treat breast cancer cells with radiotherapy to see why this is happening and find out why these genes have an impact on the success of the treatment.

Professor Prise said, "We are grateful for this funding from Breast Cancer Campaign. We hope our findings will lead to methods to predict which patients will gain limited benefit from this treatment. The course of radiotherapy could then be adapted to the individual to ensure they receive a more effective dose."

Arlene Wilkie, Director of Research and Policy, Breast Cancer Campaign said, "There are many different genes which are important in both the development and treatment of breast cancer. Identifying them and finding out more about their role is a vital area of breast cancer research and we are delighted to be funding this project."

Source
Breast Cancer Campaign

Original article posted on Medical News Today.
Articles not to be reproduced without permission of Medical News Today

Medical News Today publishes the latest health news and health videos for consumers and health professionals. It has a searchable archive of over 100,000 health news articles.





For any corrections of factual information, or to contact the editors please use our feedback form.
Send your press releases to








free web search box


pda medical dictionary
pda software - $15

PDA Medical Dictionary

only $15

Take MediLexicon's abbreviations search with you where-ever you go with our PDA software. As an extra, this software is available with an extra medical dictionary...

>> Click here for more on the PDA Medical Dictionary <<




add to google

Add our searches to your Google homepage.

Add to Google

The 60 seconds challenge: Add these searches to your Google homepage within 60 seconds - simply click here and follow these instructions


Receive the latest medical news on your Google homepage.

Add to Google

The 60 seconds challenge: Receive the latest medical news on your Google homepage within 60 seconds - simply click here and follow these instructions





Privacy Policy   |    Disclaimer      

MediLexicon International Ltd, UK Office: +44 (0) 1625 415 347
MediLexicon International Ltd © 2009 All rights reserved.